The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company reported half-year revenue up 22% to US$477 million and a strong gross margin improvement to 55%. Adjusted EBITDA surged 146% year-on-year to US$52 million.

What did Telix Pharmaceuticals report?

• Revenue rose 22% year-on-year to US$477 million, tracking to the upper end of FY26 guidance.
• Gross margin climbed to 55%, with Precision Medicine segment margin at 65%.
• Adjusted EBITDA came in at US$52 million, up 146% on the prior year.
• Profit after tax was US$38 million, including a US$40 million payment from Regeneron.
• Group R&D investment was US$124 million, mainly supporting late-stage programs.
• Positive operating cash flow of US$23 million and cash balance of US$252 million at 30 June 2026.

What else do investors need to know?

Telix announced a new strategic collaboration with Regeneron to develop and commercialise next-generation radiopharmaceutical therapies, contributing US$40 million in other income this half. The company also completed refinancing of its convertible bond structure with a new US$600 million issue due 2031.

Operationally, the Precision Medicine segment drove growth with flagship products Illuccix and Gozellix gaining market share. Key clinical milestones were achieved, including enrolment completion for late-stage trials and regulatory progress in the US, China, Europe, and Japan. Telix is also expanding its global manufacturing footprint with new and upgraded facilities in Australia, Belgium, Japan, and the US.

What did Telix Pharmaceuticals management say?

Managing Director and Group CEO, Dr Christian Behrenbruch, said:

Telix delivered an outstanding first half, with strong revenue growth, market share gains and significant progress across clinical and regulatory milestones. Our strengthened balance sheet is enabling increased investment in late-stage programs, including ProstACT Global, market expansion opportunities within our precision medicine portfolio and manufacturing and supply chain capabilities that differentiate Telix. With multiple near-term catalysts, we enter the second half with strong momentum and confidence.

What’s next for Telix Pharmaceuticals?

Telix reaffirmed FY26 revenue and other income guidance above US$1 billion, with R&D expenditure expected between US$230 million and US$270 million. The company expects ongoing clinical trial readouts and regulatory submissions in key territories later in the year.

Strategically, Telix will leverage its expanded manufacturing capacity and commercial partnerships to support commercial growth and pipeline advancement. The new at-the-market equity facility is intended to provide flexible access to capital to underpin future expansion, subject to regulatory approvals.

Telix Pharmaceuticals share price snapshot

The Telix Pharmaceuticals share price has recorded a small decline over the past 12 months, compared with a 1.5% gain from the S&P/ASX 200 index (ASX: XJO).

View Original Announcement

The post Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• After rocketing 24% last week, what are experts saying about these red hot ASX shares?
• Here are the top 10 ASX 200 shares today
• Which are the 10 most shorted ASX shares?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Autosports Group Ltd (AS:X ASG) share price is in focus today after the prestige car retailer posted record full-year revenue of $3.19 billion and normalised profit before tax up 11.1%.

What did Autosports Group report?

• Record FY26 revenue of $3.19 billion, up 11.9% year on year
• Gross profit reached $589.7 million, up 15% from FY25
• Normalised NPBT of $53.5 million, up 11.1%
• New vehicle order write climbed 20% compared to the prior year
• Order bank soared 290% since 30 June 2025
• Vehicle service and parts revenue increased by 16% and 22%, respectively

What else do investors need to know?

Autosports Group’s core prestige and luxury segments stayed resilient despite challenging market conditions, supported by strong demand for new energy and electric vehicles. The group faced stock shortages in the final quarter as accelerated demand for electric models outpaced inventory, but it maintained gross margins at 18.5%.

To fund growth and expand its network, the company increased its Syndicated Facility Agreement by $85 million to $435 million, extending maturities and relaxing some covenants. Meanwhile, new greenfield dealerships are scheduled to open in Sydney, and a key property acquisition in Canberra will strengthen its ACT operations.

What did Autosports Group management say?

Chief Executive Officer Nick Pagent said:

Our record performance reflects our disciplined growth strategy and commitment to representing brands that are future-ready. The surge in electric vehicle demand puts us in a strong position as new supply arrives.

What’s next for Autosports Group?

Autosports Group remains upbeat as it enters FY27 with new dealership launches, including Mercedes-Benz Southport and new luxury EV brands Omoda Jaecoo and XPENG in Sydney. The acquisition in Canberra underpins further expansion plans.

Management expects the record order bank to begin unwinding in the second half of FY27 as new electric vehicle supply finally meets strong demand. Additional growth is anticipated from newly acquired businesses and continued roll-out of new electric and luxury vehicles, positioning Autosports Group well in the evolving automotive market.

Autosports Group share price snapshot

Over the past 12 months, Autosports Group shares have declined 46%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Autosports Group posts record revenue and surging EV orders in FY26 appeared first on The Motley Fool Australia.

More reading

• MA Financial delivers record 1H26 earnings and lifts dividend
• Sonic Healthcare share price in focus on FY26 profit jump and digital push
• Ridley: FY26 profit jumps on fertiliser boost
• IPH Ltd FY26 earnings: resilient profit growth and higher dividend
• 2 ASX shares tipped to grow 40% or more in the next 12 months

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Fortescue Ltd (ASX: FMG) share price is in focus after the company delivered record iron ore shipments and posted a nine per cent jump in underlying EBITDA to US$8.6 billion for the year ended 30 June 2026.

What did Fortescue report?

• Revenue grew 9% to US$17.0 billion.
• Underlying EBITDA rose 9% to US$8.6 billion (margin: 51%).
• Underlying net profit after tax (NPAT) increased 3% to US$3.5 billion.
• Free cash flow up 25% to US$3.2 billion.
• Fully franked dividends for FY26 totalled A$1.08 per share (65% payout ratio).
• Net debt reduced to US$0.9 billion; cash balance at US$5.1 billion.

What else do investors need to know?

Fortescue achieved record iron ore shipments of 201.3 million tonnes, supported by ongoing operating excellence and a focus on safety, with a Total Recordable Injury Frequency Rate of 1.3. The company’s Hematite C1 unit cost was US$18.74 per wet metric tonne, within guidance despite higher energy prices.

Fortescue advanced its Green Grid strategy, progressing renewable energy projects and installing over 300,000 solar panels in the Pilbara. The company also completed the acquisition of Alta Copper, expanding its copper portfolio in Peru.

Ongoing investments in technology, including artificial intelligence for operations and energy management, are intended to boost productivity and long-term cost competitiveness.

What did Fortescue management say?

Fortescue Metals and Operations CEO Dino Otranto said:

Our record operating performance this year underpinned a nine per cent increase in Underlying EBITDA and a 25 per cent increase in free cash flow. We invested US$3.6 billion across the business and finished the year with US$5.1 billion in cash and net debt of just US$0.9 billion. That puts us in a strong position to continue investing in growth while delivering returns to shareholders.

What’s next for Fortescue?

Guidance for FY27 includes 197–207 million tonnes of iron ore shipments and a Hematite C1 unit cost between US$20.50 and US$21.75 per wet metric tonne. Planned capital expenditure is up to US$4.7 billion for metals, with an additional US$150 million earmarked for energy investments.

Fortescue will continue developing its renewable Green Grid, expanding exploration efforts, and focusing on autonomous and AI-driven efficiency improvements. The company aims to build on its strong financial position to support future growth across metals and energy.

Fortescue share price snapshot

The Fortescue share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of around 7%.

View Original Announcement

The post Fortescue hits new records in FY26: profit up, dividends flow appeared first on The Motley Fool Australia.

More reading

• How much passive income could I earn from a $630,000 superannuation balance?
• How much do I need in my superannuation to earn $50,000 per year in passive income?
• Reporting season half-time report: 5 lessons from August so far
• If I invest $10,000 in Fortescue shares, how much passive income will I receive in 2027?
• How much is needed in superannuation for $2,000 in weekly passive income?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.